Minimum non-isotropic and asymmetric margins for taking into account intrafraction prostate motion during moderately hypofractionated radiotherapy

The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy

Marcel van Herk, P. Remeijer, C. Rasch et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 1.5K citations

Medicine, Oncology, Radiation Oncology +16

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

Anders Widmark, Adalsteinn Gunnlaugsson, L. Beckman et al. · The Lancet · 2019 · 871 citations

Medicine, Radiation Oncology, Urology +16

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer

Michael J. Zeléfsky, Emily J. Levin, Margie Hunt et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 738 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

Douglas Brand, Alison Tree, Peter Ostler et al. · The Lancet Oncology · 2019 · 536 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Observations on Real-Time Prostate Gland Motion Using Electromagnetic Tracking

K Langen, Twyla R. Willoughby, Sanford L. Meeks et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 369 citations · Full text

Medicine, Biomedical Engineering, Urology +10